The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease Article Early Access

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Rossing, Peter; Baeres, Florian M. M.; Bakris, George; Bosch-Traberg, Heidrun; Gislum, Mette; Gough, Stephen C. L.; Idorn, Thomas; Lawson, Jack; Mahaffey, Kenneth W.; Mann, Johannes F. E.; Mersebach, Henriette; Perkovic, Vlado; Tuttle, Katherine; Pratley, Richard; FLOW Steering Comm; FLOW Trial Investigators

authors

Publication Date

  • January 18, 2023

webpage

published in

category

keywords

  • albuminuria
  • cardiovascular disease
  • diabetic kidney disease
  • glomerular filtration rate
  • glucagon-like peptide-1 receptor agonist